MUHC, Montreal General Hospital
Montreal, Quebec, H3G 1A4, Canada
NCT Number: NCT00901082
Patient presenting to chronic pain clinics frequently undergo diagnostic and therapeutic spinal injections as part of their treatment. These procedures can cause significant level of apprehension in patients, which can lead to increased procedural times, increased procedural pain and reluctance to continue with the treatment program. It appears that certain interventions could reduce the anxiety and catastrophization levels and modify pain perception during medical procedures. The investigators therefore sought to evaluate the effect of a single 30 minutes information session which includes relaxation training administered 5 to 6 days before the nerve block procedure on patient's anxiety and catastrophization levels prior to the procedure and pain scores during the procedure, as well as the overall level of satisfaction with care received.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Montreal, Quebec, H3G 1A4, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Relaxation and information session before the medial branch block
Time frame: 5-7 days (Second visit and Day of block)
Time frame: Throughout the study (Baseline, day of block and 1 month after)
Time frame: Baseline and day of block
Time frame: Day after the block
Time frame: Day of block
Louise Lamb
Other
The Effectiveness of Information and Relaxation on Pre-procedural Block Anxiety and Procedural Discomfort During Medial Branch Block: a Randomized Controlled Trial
Acronym: TIRAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05451589
Anxiety, Anxiety Disorders
Ann Arbor, Michigan, United States
View Trial DetailsNCT06404788
Anxiety Disorders, Anxiety Disorders and Symptoms
Katowice, Silesian Voivodeship, Poland
View Trial DetailsNCT04924244
Anxiety, Anxiety Disorders
Hershey, Pennsylvania, United States
View Trial DetailsNCT03889418
Anxiety, Anxiety Disorders
New Orleans, Louisiana, United States
View Trial Details